Reply

F Scott^{1

2}, M Menezes³, M E Smet^{1

4}, K Carey¹, T Hardy^{5

6}, T Fullston⁵, D L Rolnik^{3

7}, A McLennan^{1

8}

Affiliations

¹ Sydney Ultrasound for Women, Sydney, NSW, Australia.
² University of New South Wales, Sydney, Australia.
³ Monash Ultrasound for Women, Melbourne, Australia.
⁴ Department of Obstetrics and Gynaecology, Westmead Hospital, Sydney, Australia.
⁵ Repromed, Adelaide, Australia.
⁶ South Australia Pathology, Adelaide, Australia.
⁷ Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia.
⁸ University of Sydney, Sydney, Australia.

Free article

Comment

F Scott et al. Ultrasound Obstet Gynecol. 2022 Jan.

Free article

. 2022 Jan;59(1):128-129.

doi: 10.1002/uog.24819.

F Scott^{1

2}, M Menezes³, M E Smet^{1

4}, K Carey¹, T Hardy^{5

6}, T Fullston⁵, D L Rolnik^{3

7}, A McLennan^{1

8}

¹ Sydney Ultrasound for Women, Sydney, NSW, Australia.
² University of New South Wales, Sydney, Australia.
³ Monash Ultrasound for Women, Melbourne, Australia.
⁴ Department of Obstetrics and Gynaecology, Westmead Hospital, Sydney, Australia.
⁵ Repromed, Adelaide, Australia.
⁶ South Australia Pathology, Adelaide, Australia.
⁷ Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia.
⁸ University of Sydney, Sydney, Australia.

No abstract available

Comment on

Influence of fibroids on cell-free DNA screening accuracy.
Scott F, Menezes M, Smet ME, Carey K, Hardy T, Fullston T, Rolnik DL, McLennan A. Scott F, et al. Ultrasound Obstet Gynecol. 2022 Jan;59(1):114-119. doi: 10.1002/uog.23763. Ultrasound Obstet Gynecol. 2022. PMID: 34396623
Influence of fibroids on cell-free DNA screening accuracy: what we need to know.
Yang YD, Cao Q, Li DZ. Yang YD, et al. Ultrasound Obstet Gynecol. 2022 Jan;59(1):127-128. doi: 10.1002/uog.24818. Ultrasound Obstet Gynecol. 2022. PMID: 34985817 No abstract available.

1. Scott F, Menezes M, Smet ME, Carey K, Hardy T, Fullston T, Rolnik DL, McLennan A. Influence of fibroids on cell-free DNA screening accuracy. Ultrasound Obstet Gynecol 2021; 59: 114-119.
1. van der Meij, KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, et al., Dutch NIPT Consortium. TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands. Am J Hum Genet 2019; 105: 1091-1101.
1. Soster E, Boomer T, Hicks S, Caldwell S, Dyr B, Chibuk J, Almasri E. Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants. Genet Med 2021; 23: 1349-1355.
1. Scott F, Smet EM, Hardy T, Sundercombe S, Friedlander M, Carey L, Kirk E, Li B, McLennan A. Concurrent maternal malignancy and fetal trisomy detected using genome-wide noninvasive prenatal screening. Prenat Diagn 2021; 41: 1273-1276.
1. Van Opstal D, van Maarle MC, Lichtenbelt K, Weiss MM, Schuring-Blom H, Bhola SL, et al. Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study. Genet Med 2018; 20: 480-485.